Qu XW et al. |
Type I nitric oxide synthase (NOS) is the predominant NOS in rat small intestine. Regulation by platelet-activating factor. |
1999 |
Biochim. Biophys. Acta |
pmid:10446403
|
Shehnaz D et al. |
Effect of the crude extract of Cestrum parqui on carrageenin-induced rat paw oedema and aggregation of human blood platelets. |
1999 |
Phytother Res |
pmid:10441792
|
Dentelli P et al. |
Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation. |
1999 |
J. Immunol. |
pmid:10438956
|
Soybir G et al. |
The effects of free oxygen radical scavenger and platelet-activating factor antagonist agents in experimental acute pancreatitis. |
1999 |
Pancreas |
pmid:10438161
|
Zeng S et al. |
Regulatory role of protein tyrosine phosphorylation in platelet activating factor-induced signal transduction in platelets. |
1999 |
Zhongguo Yao Li Xue Bao |
pmid:10437164
|
Alloatti G et al. |
Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle. |
1999 |
Cardiovasc. Res. |
pmid:10435033
|
Zouki C et al. |
Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. |
1999 |
Br. J. Pharmacol. |
pmid:10433505
|
Tanaka R et al. |
Role of platelet-activating factor acetylhydrolase gene mutation in Japanese childhood IgA nephropathy. |
1999 |
Am. J. Kidney Dis. |
pmid:10430976
|
Schifitto G et al. |
Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium. |
1999 |
Neurology |
pmid:10430432
|
Fiotti N et al. |
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. |
1999 |
Atherosclerosis |
pmid:10428295
|
Maggirwar SB et al. |
HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. |
1999 |
J. Neurochem. |
pmid:10428053
|
Ambrosio G and Tritto I |
Reperfusion injury: experimental evidence and clinical implications. |
1999 |
Am. Heart J. |
pmid:10426862
|
Rodrigues CR et al. |
Proposal of a new PAF pharmacophoric map by the AM1 method. |
1999 |
Eur J Pharm Sci |
pmid:10425381
|
Asano K et al. |
Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10425216
|
Bocheński J et al. |
Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats. |
1999 |
J. Physiol. Pharmacol. |
pmid:10424723
|
Yamada M et al. |
Possible participation of intracellular platelet-activating factor in tumor necrosis factor-alpha production by rat peritoneal macrophages. |
1999 |
Eur. J. Pharmacol. |
pmid:10422778
|
Shan L et al. |
Platelet-activating factor increases the expression of metalloproteinase-9 in human bronchial epithelial cells. |
1999 |
Eur. J. Pharmacol. |
pmid:10422651
|
Panés J et al. |
Impaired mesenteric leukocyte recruitment in experimental portal hypertension in the rat. |
1999 |
Hepatology |
pmid:10421653
|
Geijsen N et al. |
Regulation of p21rac activation in human neutrophils. |
1999 |
Blood |
pmid:10419906
|
M'Rabet L et al. |
Differential fMet-Leu-Phe- and platelet-activating factor-induced signaling toward Ral activation in primary human neutrophils. |
1999 |
J. Biol. Chem. |
pmid:10419502
|